Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Intangibles (2020 - 2024)

Historic Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 8 years, with Q4 2024 value amounting to $29.2 million.

  • Amphastar Pharmaceuticals' Intangibles changed 0.0% to $29.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $29.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $29.2 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Intangibles of $29.2 million as of Q4 2024, which was down 0.0% from $29.2 million recorded in Q4 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Intangibles peaked at $29.2 million during Q4 2020, and registered a low of $29.2 million during Q4 2020.
  • In the last 5 years, Amphastar Pharmaceuticals' Intangibles had a median value of $29.2 million in 2020 and averaged $29.2 million.
  • Examining YoY changes over the last 5 years, Amphastar Pharmaceuticals' Intangibles showed a top increase of 0.0% in 2021 and a maximum decrease of 0.0% in 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Intangibles (Quarter) stood at $29.2 million in 2020, then changed by 0.0% to $29.2 million in 2021, then changed by 0.0% to $29.2 million in 2022, then changed by 0.0% to $29.2 million in 2023, then changed by 0.0% to $29.2 million in 2024.
  • Its Intangibles was $29.2 million in Q4 2024, compared to $29.2 million in Q4 2023 and $29.2 million in Q4 2022.